For This Woman With Arthrogryposis Multiplex Congenita, This New Barbie is Life-Changing
Alexas_Fotos / Pixabay

For This Woman With Arthrogryposis Multiplex Congenita, This New Barbie is Life-Changing

According to a story from the Huffington Post, a recent Instagram post from the Barbie brand of dolls indicates that the company is beginning to expand its line of dolls…

Continue Reading For This Woman With Arthrogryposis Multiplex Congenita, This New Barbie is Life-Changing

Patient Advocate Foundation Provides Co-Pay Relief for Rare Disease Patients

What is the Patient Advocate Foundation? The Patient Advocate Foundation (PAF) is a non-profit, formed in 1994 that has one primary aim- eliminate the barriers to treatment too many patients…

Continue Reading Patient Advocate Foundation Provides Co-Pay Relief for Rare Disease Patients

New Device Could Help Langerhans Cell Histiocytosis Patients Monitor Their Own Chemotherapy Treatments

Langerhans Cell Histiocystosis Langerhans Cell Histiocytosis (LCH) Is a rare form of cancer caused by an excessive amount of Langerhan cells in the body. These cells form granulomas which can have a…

Continue Reading New Device Could Help Langerhans Cell Histiocytosis Patients Monitor Their Own Chemotherapy Treatments
Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease
argzombies / Pixabay

Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease

According to a story from BioSpace, the biopharmaceutical company Modis Therapeutics recently announced that the US Food and Drug Administration (FDA) has granted Breakthough Therapy designation for the company's experimental…

Continue Reading Experimental Treatment Earns Breakthrough Therapy Designation for TK2 Deficiency, a Form of Mitochondrial Disease

Experimental Treatment for Macular Telangiectasia Type 2 Earns Fast Track Designation

According to a story from prnewswire.com, the biopharmaceutical company Neurotech Pharmaceuticals recently announced that the company had earned Fast Track designation from the US Food and Drug Administration (FDA). This…

Continue Reading Experimental Treatment for Macular Telangiectasia Type 2 Earns Fast Track Designation
New Collaborative Effort Will Test a Potential Treatment for Sanfilippo Syndrome
Nappiness / Pixabay

New Collaborative Effort Will Test a Potential Treatment for Sanfilippo Syndrome

According to a story from Market Screener the biotechnology company Bioblast Pharma has announced a new partnership with Team Sanfilippo a nonprofit foundation which is committed to medical research related…

Continue Reading New Collaborative Effort Will Test a Potential Treatment for Sanfilippo Syndrome